ERBB2 and breast cancer: Breast cancer, which is often driven by different oncogenes such as HER2 and estrogen receptor (ER) pathways presents many nuclear abnormalities that include irregular nuclear shape, enlarged nuclear size, increased nuclear to cytoplasmic ratio, and nuclear invaginations.